INTRODUCTION:‎
Chronic kidney disease (CKD) is characterized by the gradual decline of renal function, initially ‎presenting with no symptoms and progressing to manifestations such as lower limb edema, ‎exhaustion, nausea, and vomiting. CKD is caused by various factors including hypertension, ‎diabetes mellitus, genetic disorders, and autoimmune diseases. Diagnosis involves measuring ‎estimated glomerular filtration rate (GFR), urinary albumin levels, and sometimes ultrasound or ‎kidney biopsy. Differentiating between CKD and acute kidney injury (AKI) is crucial as AKI is ‎reversible while CKD is irreversible. End-stage renal disease (ESRD) necessitates chronic ‎hemodialysis, often requiring vascular access (VA) creation. Treatment options for ESRD include ‎central dialysis catheters (CDCs), arteriovenous fistulae (AVFs), and arteriovenous grafts ‎‎(AVGs). Complications of VA include infection, stenosis, thrombosis, and nerve-related issues ‎such as ischemic monomelic neuropathy (IMN) and nerve compression. Early detection and ‎intervention are crucial for minimizing complications and optimizing patient outcomes. Nerve ‎conduction tests post-AVF creation can aid in identifying potential nerve-related complications, ‎allowing for timely management.‎